Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirshner

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|January 23, 2021
Preclinical PET imaging with the novel human antibody <sup>89</sup>Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissuesMarcus P Kelly, Sosina Makonnen, Carlos Hickey, et al.
Bioorganic & Medicinal Chemistry|October 25, 2020
Antibody drug conjugates of cleavable amino-benzoyl-maytansinoidsThomas Nittoli, Frank Delfino, Marcus Kelly, et al.
Science Advances|January 21, 2026
Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumorsCorinne E Decker, Jacqueline Idun, Katja Mohrs, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Scientific Reports|December 15, 2015
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeysEric J Smith, Kara Olson, Lauric J Haber, et al.
Bioorganic & Medicinal Chemistry|April 2, 2018
Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoidsThomas Nittoli, Marcus P Kelly, Frank Delfino, et al.
Molecular Pharmaceutics|April 24, 2018
ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor XenograftsSarah M Cheal, Shutian Ruan, Darren R Veach, et al.
The Astrophysical Journal|July 8, 2017
Ejection of the Massive Hydrogen-rich Envelope Timed with the Collapse of the Stripped SN 2014CRaffaella Margutti, A Kamble, D Milisavljevic, et al.
Science Translational Medicine|June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancerAlison Crawford, Lauric Haber, Marcus P Kelly, et al.
Cancer Immunology Research|July 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054Richard Tavaré, Makenzie Danton, Jason T Giurleo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|January 23, 2021
Preclinical PET imaging with the novel human antibody <sup>89</sup>Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissuesMarcus P Kelly, Sosina Makonnen, Carlos Hickey, et al.
Bioorganic & Medicinal Chemistry|October 25, 2020
Antibody drug conjugates of cleavable amino-benzoyl-maytansinoidsThomas Nittoli, Frank Delfino, Marcus Kelly, et al.
Science Advances|January 21, 2026
Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumorsCorinne E Decker, Jacqueline Idun, Katja Mohrs, et al.
Molecular Cancer Therapeutics|April 6, 2017
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast CancersMarcus P Kelly, Carlos Hickey, Sosina Makonnen, et al.
Scientific Reports|December 15, 2015
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeysEric J Smith, Kara Olson, Lauric J Haber, et al.
Bioorganic & Medicinal Chemistry|April 2, 2018
Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoidsThomas Nittoli, Marcus P Kelly, Frank Delfino, et al.
Molecular Pharmaceutics|April 24, 2018
ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor XenograftsSarah M Cheal, Shutian Ruan, Darren R Veach, et al.
The Astrophysical Journal|July 8, 2017
Ejection of the Massive Hydrogen-rich Envelope Timed with the Collapse of the Stripped SN 2014CRaffaella Margutti, A Kamble, D Milisavljevic, et al.
Science Translational Medicine|June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancerAlison Crawford, Lauric Haber, Marcus P Kelly, et al.
Cancer Immunology Research|July 27, 2022
Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054Richard Tavaré, Makenzie Danton, Jason T Giurleo, et al.
Pageof 4